You can find the annual or quarterly income statement of Propanc Biopharma Ord Shs here for insights into the performance and operational efficiency of Propanc Biopharma Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q3

FY2026Q2

FY2026Q1

Total revenue

----

--0.00

Revenue

----

--0.00

Operating expenses

--6.40M

--3.65M

--4.67M

R&D expenses

--169.66K

--19.96K

--60.20K

Depreciation, depletion, and amortization

----

--229.00

--125.00

Operating profit

---6.40M

---3.65M

---4.67M

Net non-operating interest income (expenses)

Non-operating interest income

--13.00

--37.00

--19.00

Non-operating interest expense

--38.27K

--58.95K

--305.65K

Gains from sale of securities

--35.01K

---19.50K

---34.70K

Special income (expenses)

--90.14K

--695.75K

--176.16K

Other non-operating income (expenses)

---47.00K

---54.00K

----

Income before tax

---6.36M

---3.09M

---4.84M

Income tax

--0.00

----

Income after tax

---6.36M

---3.09M

---4.84M

Net income from continuous operations

----

---3.09M

---4.84M

Net income attributable to controlling interests

----

---4.02M

---4.84M

Net income attributable to common shareholders

----

---4.02M

---4.84M

Basic earnings per share

---0.28

---0.30

---0.39

Diluted earnings per share

---0.28

---0.30

---0.39

Dividend per share

----

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

